We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-13.49%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$298M
AUM Growth
-$121M
Cap. Flow
-$79.8M
Cap. Flow %
-26.73%
Top 10 Hldgs %
49.77%
Holding
104
New
36
Increased
13
Reduced
16
Closed
35

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$23.2M
2
NVST icon
Envista
NVST
+$21.9M
3
BSX icon
Boston Scientific
BSX
+$15.5M
4
BIIB icon
Biogen
BIIB
+$12.7M
5
GLD icon
SPDR Gold Trust
GLD
+$9.63M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$16.7M
2
PFE icon
Pfizer
PFE
+$14.9M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$14.8M
4
GILD icon
Gilead Sciences
GILD
+$12.1M
5
GSK icon
GSK
GSK
+$9.62M

Sector Composition

Rank Sector Weight
1 Healthcare 83.72%
2 Financials 0.58%
3 Technology 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFNX
101
DELISTED
Pfenex Inc.
PFNX
-232,626
Closed -$2.55M
WCG
102
DELISTED
Wellcare Health Plans, Inc.
WCG
-44,935
Closed -$14.8M
BEAT
103
DELISTED
BioTelemetry, Inc.
BEAT
-160,015
Closed -$7.41M
BEAT
104
PUT
DELISTED
BioTelemetry, Inc.
BEAT
-28,200
Closed -$1.31M

Similar funds

Sio Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Sio Capital Management held 104 positions worth $298M, down 29% from $420M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Sio Capital Management withdrew a net $79.8M in Q1 2020, closing 35 positions and reducing 16 holdings. Its most notable exit was Medtronic, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 72% a quarter earlier, followed by Financials and Technology.

Against the trend, Sio Capital Management opened a new position in Amgen worth $21.5M.

  • Sio Capital Management's largest Q1 2020 buy was Amgen: 106,069 shares worth $21.5M.
  • Sio Capital Management added most to McKesson in Q1 2020, an estimated $9.36M increase.
  • Sio Capital Management's biggest Q1 2020 reduction was Trillium Therapeutics Inc., cutting an estimated $8.82M.
  • Sio Capital Management fully exited Medtronic in Q1 2020, selling an estimated $16.7M.
  • Sio Capital Management's ten largest holdings make up 50% of its $298M portfolio in Q1 2020.
  • Sio Capital Management opened 36 new positions and closed 35 in Q1 2020.
  • Sio Capital Management's portfolio value fell 29% quarter-over-quarter to $298M.

Based on Sio Capital Management's 13F filing for Q1 2020, filed 15 May 2020.